about
N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionRole of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of StrokeTowards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus reportU0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female ratsMethylene Blue Reduces Acute Cerebral Ischemic Injury via the Induction of Mitophagy.In Vivo Inhibition of miR-155 Promotes Recovery after Experimental Mouse StrokeOverview of Glutamatergic Dysregulation in Central Pathologies.Susceptibility of Primary Sensory Cortex to Spreading Depolarizations.Neuropathophysiology of Brain Injury.Neuroplastic Changes Following Brain Ischemia and their Contribution to Stroke Recovery: Novel Approaches in Neurorehabilitation.Strategies for early stroke recovery: what lies ahead?Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke.The 3 Rs of Stroke Biology: Radial, Relayed, and Regenerative.Post-acute delivery of memantine promotes post-ischemic neurological recovery, peri-infarct tissue remodeling, and contralesional brain plasticity.GAT3 selective substrate l-isoserine upregulates GAT3 expression and increases functional recovery after a focal ischemic stroke in mice.Neovascularization and Synaptic Function Regulation with Memantine and Rosuvastatin in a Rat Model of Chronic Cerebral Hypoperfusion.Pharmacotherapy and motor recovery after stroke.Treatments to Promote Neural Repair after Stroke.
P2860
Q30145688-E9A54B12-016C-49E3-8DB6-B7C7945C3374Q33565967-289D6DFE-AC01-4EA1-AB6F-3251B734CFDEQ33726628-8CC3CBE2-9A81-495D-9502-0E6EFBA903E3Q35143502-64CC3813-6EEA-4559-871A-16A380DA4E0BQ36025683-F888E5F8-3D22-493A-8712-6BC74B35E6A6Q36038242-F6468D5E-A197-4758-AA93-D7F18111A4D3Q36409596-A732BEE6-DBC8-4DF1-A940-FB65D6371472Q36840527-6B8C5D2E-55E6-421C-9516-6B29F1FFB4E9Q37559491-FAC3A6E6-03EA-4D23-87EB-4345A810A921Q37703086-1A5AB770-5C4D-47C7-9F52-0A1EB8F77527Q38268307-D04DC01D-FFFB-435B-97EC-79412DBB9980Q38595982-0ABCB642-F870-4B31-8CE9-9DB1956042B2Q38646400-738576AF-0AD0-4DA8-A86B-4C31B31729F2Q39773096-5953655C-A530-443B-8529-B004B8A1361AQ47379258-36C4F258-6B37-4128-8787-52E9A0FDD4C6Q47881880-0C306932-6112-4C69-9E87-E5921FC5260AQ47975906-8A641DCB-97CC-4014-9DC6-052257EDC772Q50062335-23D338AE-0C01-4F78-8298-CCB723C57A04
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Memantine enhances recovery from stroke.
@ast
Memantine enhances recovery from stroke.
@en
Memantine enhances recovery from stroke.
@nl
type
label
Memantine enhances recovery from stroke.
@ast
Memantine enhances recovery from stroke.
@en
Memantine enhances recovery from stroke.
@nl
prefLabel
Memantine enhances recovery from stroke.
@ast
Memantine enhances recovery from stroke.
@en
Memantine enhances recovery from stroke.
@nl
P2093
P2860
P50
P1433
P1476
Memantine enhances recovery from stroke
@en
P2093
Andrew C Charles
Michael V Sofroniew
P2860
P304
P356
10.1161/STROKEAHA.113.004476
P407
P577
2014-06-17T00:00:00Z